Vaccines (for HIV Prevention)

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Show Archived (Historical) Articles

The Basics

Statement of Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day (May 18, 2008)
From National Institute of Allergy and Infectious Diseases
2008 AVAC Report The Search Must Continue (May 2008)
From AIDS Vaccine Advocacy Coalition
Scientists No Closer to Developing HIV Vaccine Than 20 Years Ago, AAAS President Says (February 19, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
An Update Regarding the HVTN 502 and HVTN 503 HIV Vaccine Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
Questions and Answers: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
Philadelphia Inquirer Examines Effect of Merck's Failed International HIV Vaccine Trial on Research and Development (October 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Why Is There Still No Vaccine for HIV? (Summer 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
NIAID Statement on HIV Vaccine Awareness Day (May 18, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges (May 16, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
On HIV Vaccine Awareness Day, Researchers and Activists Mark 10 Years of Hunting (May 11, 2007)
In Southern Voice
NIAID Statement on HIV Vaccine Awareness Day, May 18, 2006 (May 15, 2006)
Dr. Anthony Fauci and colleagues urge greater funding and support for vaccine development.
From U.S. National Institute of Allergy and Infectious Diseases
Leading HIV Vaccine Researcher Emilio Emini Leaves International AIDS Vaccine Initiative for Wyeth (November 4, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Black People and the Search for an HIV Vaccine (November/December 2005)
African-American vaccine advocate Steve Wakefield addresses some common myths African Americans may hold about HIV vaccines.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Even an Imperfect HIV Vaccine Can Save Millions of Lives, Report Says (PDF) (October 2005)
From International AIDS Vaccine Initiative
Preventive Technologies Pipeline: Vaccines (September 29, 2005)
In TAGline, from Treatment Action Group
Why Does an Effective HIV Vaccine Remain Elusive? (August 25, 2005)
University of Michigan Medical School professor Howard Markel, M.D., Ph.D., explains some of the roadblocks.
In New England Journal of Medicine
Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research (August 8, 2005)
Widespread misconceptions about HIV vaccines; most Americans support vaccine research, but do not support vaccine study participation.
From U.S. National Institute of Allergy and Infectious Diseases
Science Magazine Examines Feasibility of HIV Vaccine (July 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
AIDS Vaccine Handbook, 2nd Edition: Global Perspectives (May 2005)
A comprehensive overview of the key scientific, policy, social, ethical and economic challenges to creating an AIDS vaccine
To read PDF, click here.
From AIDS Vaccine Advocacy Coalition
HIV Vaccines: Questions and Answers for HIV Treatment Advocates (February 23, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
African Americans: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
Health Care Professionals: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
HIV Vaccines Explained (PDF) (January 2005)
Making HIV vaccines a reality.
From National Institute of Allergy and Infectious Diseases
Women: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
Myths About HIV Vaccines and Vaccine Research (PDF) (December 7, 2004)
A fact sheet that addresses African Americans' misconceptions about HIV vaccine research.
From Black AIDS Institute
Battling the Enemy on Many Fronts: Inside the Science of HIV Vaccine Development (December 2004)
In Body Positive, from Body Positive
HIV Vaccine Development and Volunteering for Vaccine Trials (December 2004)
An interview with Dr. Beryl Koblin, principal investigator for Project ACHIEVE, an AIDS vaccine advocacy organization in New York City.
In Body Positive, from Body Positive
Challenges in Designing HIV Vaccines (May 2004)
From U.S. National Institute of Allergy and Infectious Diseases
HIV Vaccines and Your Immune System (May 2004)
From Project Inform
HIV Vaccine Not Likely in Next Decade, UNAIDS Executive Director Says (March 23, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Interview With Peggy Johnston, Ph.D., on the Current State of Vaccine Research (Spring 2004)
Dr. Johnston is the Director of AIDS Vaccine Research and Prevention at NIAID.
In Positives for Positives, from Wyoming: Positives for Positives
Understanding Vaccines: What They Are, How They Work (PDF) (July 2003)
From National Institute of Allergy and Infectious Diseases
Don't Expect AIDS Vaccine Before 2009, Experts Say (June 19, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On the Trail of a Vaccine: An Interview With David M. Gold, J.D. (September/October 2002)
In Positive Living, from AIDS Project Los Angeles
Hope in a Vial: Will There Be an AIDS Vaccine Anytime Soon? (June 2002)
A fabulous analysis of the current vaccine situation.
In Scientific American
Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
AIDS Fighters Redouble Vaccine Effort (November 2001)
In Body Positive, from Body Positive
HIV Vaccine: How Close Are We? (November 2001)
In OUTReach, from San Francisco AIDS Foundation
AIDS Vaccine Update (October 1, 2001)
In Being Alive
HIV 101: HIV Vaccine Candidates (October 2001)
To read PDF, click here
In HEPP News, from Brown Medical School
Vaccines: Major Conference Sept. 5-8 in Philadelphia (July 27, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
Susan Dentzer Reports on the Latest Efforts to Create a Vaccine Against AIDS (June 27, 2001)
In PBS MacNeil-Lehrer News Hour
AIDS Vaccines: The Ethical and Social Issues (Summer 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Vaccines Therapy (May 2001)
From AIDS Community Research Initiative of America
AIDS Vaccine Development (February 9, 2001)
From HIV InSite
A Media Handbook for HIV Vaccine Trials for Africa (PDF) (February 2001)
From UNAIDS
How Close Is the AIDS Vaccine? (November 13, 2000)
In Fortune Magazine
Booster Shot: A Vaccine Primer and Update (November/December 2000)
In GMHC Treatment Issues, from Gay Men's Health Crisis
HIV Vaccine Glossary (May 2000)
From U.S. National Institute of Allergy and Infectious Diseases
AIDS Vaccine 2001 Conference
The Economics of AIDS Vaccines
The Global Alliance to Immunize Against AIDS

Clinical Trials

International AIDS Vaccine Research Database of AIDS Vaccines in Human Trials (Regularly Updated)
From International AIDS Vaccine Initiative
NIAID Director Fauci Cancels Planned HIV Vaccine Trial (July 18, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Large-Scale Trial of Merck's Experimental HIV Vaccine to Begin in South Africa (February 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
NIH Launches Phase II Trial of HIV Vaccine for Three Strains of Virus (October 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Indian Government Approves Another HIV Vaccine for Phase I Clinical Trial (July 18, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
India Begins Phase I Clinical Trial for HIV Vaccine Targeting C Strain (February 8, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
NIAID Begins Enrolling Volunteers for Novel HIV Vaccine Study (January 24, 2005)
A news release announcing the launch of this Phase II trial, called the Step Study; worldwide study locations and eligibility criteria are listed.
From U.S. National Institute of Allergy and Infectious Diseases
Timeline for the Initiation of the RV144 Prime-Boost Trial (January 2005)
In TAGline, from Treatment Action Group
Before You Volunteer for an HIV Vaccine Trial ... (December 2004)
Some key points to consider before you sign those enrollment forms.
In Body Positive, from Body Positive
Here's My Arm: My Personal Experience Participating in an HIV Vaccine Trial (December 2004)
By Gloria Abitol.
In Body Positive, from Body Positive
HIV Vaccine Development and Volunteering for Vaccine Trials (December 2004)
An interview with Dr. Beryl Koblin, principal investigator for Project ACHIEVE, an AIDS vaccine advocacy organization in New York City.
In Body Positive, from Body Positive
Keeping Hope Alive: Myths and Facts About HIV Vaccine Trials (December 2004)
Communicating the basic concepts around HIV vaccine development involves understanding some simple ideas.
In Body Positive, from Body Positive
Treatment Action Group Criticizes U.S.-Sponsored RV144 ALVAC/AIDSVAX "Prime-Boost" Vaccine Trial in Thailand (September 28, 2004)
In TAGline, from Treatment Action Group
For HIV-Negative People, the Time to Get Involved Is Now (July/August 2004)
HIV-negative people can play a pivotal role in the development of an HIV vaccine by taking part in early clinical trials.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
One Step Forward: Merck Vaccine Moves Forward With Efficacy Trial, While Special Committee Tries to Salvage Thai Study (July 2004)
In TAGline, from Treatment Action Group
ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas (June 30, 2004)
In AIDS Treatment News, from AIDS Treatment News
Thailand to Present Vaccine Results From Phase III HIV Vaccine Trial During XV International AIDS Conference (June 9, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Joining a Preventive HIV Vaccine Clinical Trial: Benefits and Risks (May 2004)
To read PDF, click here
In WISE Words, from Project Inform
Rwanda to Join African Trials for AIDS Vaccine (March 15, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Chiron Begins Human Clinical Trials of Combination of Two HIV Vaccines (January 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Group of Scientists Questions Value, Cost of Federally Funded AIDS Vaccine Trial in Thailand (January 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
U.S. Government Defends RV 144, an Ongoing HIV Vaccine Efficacy Trial in Thailand (January 15, 2004)
From U.S. National Institute of Allergy and Infectious Diseases
The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light (October 2003)
Further analysis of AIDSVAX's efficacy -- or lack thereof -- in minorities.
In TAGline, from Treatment Action Group
Merck HIV Vaccines Progress Through Safety Trials (September 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
South Africa's Medicines Control Council Approves Country's Second HIV Vaccine Clinical Trial (August 27, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Botswana Human Rights Group Says Country Offers No Protection to Participants in HIV Vaccine Trial (August 19, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
U.S. Company Denies Plan to Abandon AIDS Vaccine Test in Thailand (July 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Race Is On to Save the First AIDS Vaccine. But Does It Even Work? (July 1, 2003)
VaxGen pulls out of a final set of trials for its AIDSVAX vaccine amid claims of hype and manipulation.
In The Guardian
South Africa to Test First Vaccine Against HIV Subtype C (June 20, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Biotech Firm to Test AIDS Vaccine (June 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Italian HIV Vaccine Trial Ready to Begin (June 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Australian-Developed HIV Vaccine Trial Announced (June 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Trials of AIDS Vaccine to Start in India (May 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Debate Over Vaccine Trial Results Hits Racial Divide (April 1, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
A Worthwhile Test of Hope; Despite Negative Results, Subjects Are Glad They Volunteered for AIDS Vaccine Trial (March 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Against the Odds, Company Works on AIDS Vaccine (November 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
First Human Trial of "Global" HIV Vaccine Launched (November 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New HIV Vaccine Holds Promise of Global Effectiveness (November 13, 2002)
From U.S. National Institutes of Health
Clinical Trials of India-Specific Anti-AIDS Vaccine to Start in 2003 (April 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Arizonans to Take Part in Study for an AIDS Vaccine (March 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Albany-Area AIDS Vaccine Testers Needed for Study at Albany Medical College (March 19, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Maryland: Institute of Human Virology Plans Clinical Trial of AIDS Vaccine (March 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
NIAID Phase III HIV Vaccine Trial in the United States Will Not Proceed (March 11, 2002)
Further explanation for why one of the U.S. government's two vaccine trials is being called off.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
A Treatment Issues Editorial: Canarypox in the Coal Mine (March 2002)
The dangers of moving ahead with huge vaccine trials before the science supports them.
In GMHC Treatment Issues, from Gay Men's Health Crisis
NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases
First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial (October 9, 2001)
From National Institute of Allergy and Infectious Diseases
Vaccine Advance: Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway (March 2001)
In TAGline, from Treatment Action Group
First HIV Vaccine for Africa Begins Trials (January 26, 2001)
In AIDS Treatment News, from AIDS Treatment News
New Oral DNA Vaccine Funded for Trials (June 2, 2000)
A new kind of vaccine uses a harmless bacterium to deliver selected parts of HIV to immune cells in the intestinal membranes.
In AIDS Treatment News, from AIDS Treatment News

Initiatives & Recommendations

Center for HIV-AIDS Vaccine Immunology (Regularly Updated)
TAG's Response to NIAID "Request for Information" on Priorities in Basic HIV Vaccine Research (June 4, 2008)
From Treatment Action Group
PAVE Gives Pause: Position Statement on the Proposed PAVE100A Vaccine Trial (May 30, 2008)
From Treatment Action Group
Updated, Annotated Preventive Vaccine Pipeline Table (May 29, 2008)
Information on the current preventive HIV vaccine pipeline, annotated with commentary and links to published and presented data.
From Treatment Action Group
More Human Clinical Research on HIV Vaccine Needed to Find "Magic Formula," Says Opinion Piece (April 14, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Newspapers Publish Opinion Piece, Letter to Editor Responding to Suggestions on Future of HIV Vaccine Research (April 11, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIV/AIDS Vaccine Researchers at NIH Meeting Call for Increase in Basic Research, New Strategies (March 26, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
U.S. Should Fund HIV/AIDS Strategies "That Work," Not "Expensive Vaccine Research," Opinion Piece Says (March 25, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Gates Foundation, Canadian Government Announce Joint Initiative to Develop HIV/AIDS Vaccine (February 21, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Ads Urge Youths to Help End AIDS by Volunteering for Vaccine Studies (October 11, 2006)
From National Institute of Allergy and Infectious Diseases
Gates Foundation Pledges $287 Million for HIV Vaccine Research (July 20, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
African Americans: Answers About HIV Vaccine Research (June 2006)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases
An Interview With Barton Haynes (December 2005)
A new virtual center.
In IAVI Report, from International AIDS Vaccine Initiative
World Risks Duplication in AIDS Vaccine Push, International AIDS Vaccine Initiative Official Says (September 14, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Canadian Network of Vaccine Researchers' National Funding Grant Not Renewed (July 20, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
NIAID Establishes Consortium to Research, Develop HIV Vaccines (July 18, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
NIAID Funds Center for HIV/AIDS Vaccine Immunology (July 14, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
U.S. Spurs New Initiative on Vaccine Development -- But Some Critics Are Worried (June 15, 2004)
From MotherJones.com
G8 Countries Agree to Form Global HIV Vaccine Consortium (June 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
G8 Summit Participants to Endorse Formation of HIV/AIDS Vaccine Consortium (June 9, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Interview With Anthony Fauci, M.D., Director of NIAID, on the HIV Vaccine Enterprise (Summer 2004)
An unofficial, international consortium seeks to coordinate vaccine development worldwide.
In Positives for Positives, from Wyoming: Positives for Positives
Merck Vaccine Research Official to Join AIDS Vaccine Initiative (January 13, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
University of Alabama Wins $16 Million Grant to Develop Possible HIV Vaccine (August 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New York Times, Washington Post Examine Vaccine Projects of Bill & Melinda Gates Foundation (July 14, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
VaxGen Granted $2M to Continue HIV Vaccine Research (June 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Fighting AIDS: The Quest for an HIV Vaccine (May 19, 2003)
A statement from the HIV Research Section of the AIDS Office in the San Francisco Department of Public Health.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Merck and Aventis Will Combine HIV Vaccines (March 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
South African Scientists to Begin Manufacturing New Vaccines Aimed at Preventing AIDS (September 27, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
An AIDS Vaccine: When? (September/October 2002)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Scientists Optimistic That AIDS Vaccine Could Be Developed in Africa (June 4, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
NIAID Teams With Wyeth on HIV/AIDS Vaccine (May 17, 2002)
From U.S. National Institute of Allergy and Infectious Diseases
HIV Vaccine Research Is "Best Hope" for Controlling AIDS Pandemic (May 16, 2002)
Fifth Annual HIV Vaccine Awareness Day to highlight progress, goals for future.
From U.S. National Institute of Allergy and Infectious Diseases
What's in Glaxo's HIV Vaccine? (March 1, 2002)
In TAGline, from Treatment Action Group
NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases
NIAID and Merck to Collaborate on HIV Vaccine Development (December 20, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
Closer to AIDS Vaccine? (September 5, 2001)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Fauci to Present AIDS Vaccine Update at Philadelphia Meeting (September 4, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
Human AIDS Vaccine Trials Due in March 2002 (August 14, 2001)
From United Nations Integrated Regional Information Networks
AIDS Vaccines and Activism: Interview with Jon Cohen (June 29, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
Vaccine Vitriol: Call for Poor Country Focus on Treatment, Care Programs Elicits Voice of Concern from Vaccine Outfit (June 2001)
In TAGline, from Treatment Action Group
New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys (March 8, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
AIDS Research Past and Future: An Interview with Jeffrey Laurence, M.D. (December 2000)
From American Foundation for AIDS Research
Perfect Vaccine for HIV Not Likely, Researcher Warns (November 2000)
In Body Positive, from Body Positive
African Scientists Launch Vaccine Strategy for the Continent (July 13, 2000)
From UNAIDS
Thai AIDS Vaccines (July 13, 2000)
(This is an audio file).
From National Public Radio
NIH Announces New International Network to Study HIV Prevention Strategies (July 12, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
News & Notes: TAG Finds Need for New Funding Priorities in Vaccine (June 2000)
In Body Positive, from Body Positive
Resources for HIV Vaccine Research and Development (May 2000)
From U.S. National Institute of Allergy and Infectious Diseases
Seven Years and Counting... How Can We Overcome Obstacles to an AIDS Vaccine? (PDF) (May 2000)
The annual report about AIDS vaccines.
From AIDS Vaccine Advocacy Coalition
Vaccine News (March 17, 2000)
In AIDS Treatment News, from AIDS Treatment News
Vaccine and Microbicide Tax Credit Legislation Introduced in Congress (April 2, 1999)
From AIDS Treatment News
AIDS Vaccine Advocacy Coalition
Up-to-date information and links related to citizen advocacy for HIV vaccines.
HIV Vaccines in Canada: Legal and Ethical Issues
An overview paper and accompanying series of info sheets.
From Canadian HIV/AIDS Legal Network

Activism

HIV Vaccine Awareness Day 2005: Statement by NIAID Director Anthony S. Fauci (May 18, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
Men Inspiring Hope: Eighth Annual HIV Vaccine Awareness Day Focuses on Men Who Have Sex With Men (May 17, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
Vaccine Trial RV144 Squanders Public Goodwill and Scarce Research Funds -- But to What End? (January 2005)
An AIDS advocacy group questions the wisdom of RV144, an ongoing "prime-boost" Phase III vaccine trial in Thailand.
In TAGline, from Treatment Action Group
IAVI Statement on 2004 HIV/AIDS Statistics: New Technologies Key to Prevention (November 23, 2004)
Vaccines and microbicides could be key to reversing the growing HIV rate among women worldwide, the International AIDS Vaccine Initiative says.
From International AIDS Vaccine Initiative
Seventh Annual HIV Vaccine Awareness Day Highlights Slow Progress on Development (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Atlanta to Hold Events for HIV Vaccine Awareness Day (May 17, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Brother-to-Brother Receives Funds to Raise Awareness About HIV Vaccine Research in Hard-to-Reach Populations (March 26, 2004)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
Top HIV/AIDS Researchers Push for Greater Vaccine Effort (June 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
International HIV Vaccine Awareness Day: May 18, 2003 (May 16, 2003)
From U.S. National Institute of Allergy and Infectious Diseases
Many Americans Think an HIV/AIDS Vaccine Already Exists (May 15, 2003)
From U.S. National Institute of Allergy and Infectious Diseases
Consensus Statement (March 2003)
In TAGline, from Treatment Action Group
Net Return Plunges for AIDS Vaccine Rides (March 12, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Advocating for Improved AIDS Vaccine Policies (November 2001)
In OUTReach, from San Francisco AIDS Foundation
Fourth Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research (May 14, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
Third Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research (May 15, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
Vaccines: Call Congress to Support R&D Tax Credit (April 21, 2000)
In AIDS Treatment News, from AIDS Treatment News
Nine Years and Counting: Will We Have an HIV Vaccine by 2007? (May 1998)
An Agenda for Action for an HIV Vaccine.
From AIDS Vaccine Advocacy Coalition

Recent Findings

IAVI Report Online (Regularly Updated)
A centralized source of information on all aspects of AIDS vaccine research and associated scientific disciplines.
From International AIDS Vaccine Initiative
The Failed HIV Vaccine, the HPV Vaccine Hullabaloo and the Future of HIV Prevention (January 2008)
To read PDF, click here
In HHS Watch, from Community HIV/AIDS Mobilization Project
Merck HIV Vaccine Trial Results: Hopes Dim for Struggling Field (Winter 2008)
To read PDF, click here
In TAGline, from Treatment Action Group
Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo (November 14, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Merck Halts International HIV Vaccine Trial (September 24, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate (September 21, 2007)
From Merck & Co., Inc.
Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (September 1, 2007)
In Journal of Acquired Immune Deficiency Syndromes
AIDS Vaccine Update (July-December 2007)
Disappointment and questions after candidate fails in the STEP study.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Male Circumcision Reduces Men's HIV Infection Risk by 65%, Data Re-Evaluation Says (February 23, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development (February 14, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
VAX Primer: Understanding the Early Stages of HIV Infection (April 2006)
How can studying what happens immediately following HIV infection help researchers design an AIDS vaccine?.
From International AIDS Vaccine Initiative
Enrolling Women Into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge (February 21, 2006)
In PLoS Medicine
HIV Vaccine's CD4+ Cell-Boosting Properties Lead Merck to Double Enrollment in Study (September 23, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
A Promising Alternative: Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges (August 2005)
A study by researchers at Emory University and Merck.
In PLoS Medicine
Phase I Trial of Italian HIV Vaccine Trial Successful, Researchers Say; Phase II To Test Vaccine in Africa (July 7, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Health Affairs Focuses on Vaccines, Features Interview With Thompson; Kaiser Family Foundation Describes Media Campaigns (May 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
International AIDS Vaccine Initiative Releases Several Working Papers, Brief (April 26, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Treble Damages: Three Highlighted Studies From the AIDS Vaccine 2004 Conference (October 2004)
Disappointment clouded this year's conference, with new study results suggesting that current approaches to vaccine development aren't panning out.
In TAGline, from Treatment Action Group
Slow but Real Progress on the AIDS Vaccine Front (September 3, 2004)
Highlights from the AIDS Vaccine 04 conference.
From aidsmap.com
Researchers Identify Mutations That Help HIV Avoid Immune Detection; Implications for Vaccine Development (June 2, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV More Vulnerable to Vaccine During Acute Infection, Study Suggests (March 26, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases
Researcher Loses HIV Vaccine Data in Durban Mugging (August 6, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Antibody Discovery Could Lead to HIV Vaccine: Study (July 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New HIV Vaccine Shows Promising Results in Preclinical Studies (June 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Nabbing the V3 Loop (May 2003)
Susan Zolla-Pazner offers new insight into why some anti-V3 loop antibodies have broad HIV neutralizing ability.
In TAGline, from Treatment Action Group
Starting Anew (Again) (April 2003)
CROI 2003 updates on vaccines, siRNA therapy, CEM15 deactivation and the therapeutic value of GBV-C.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
AIDS Groups Call for Review of AIDS Vaccine Trial Results (March 31, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Virion-Based Vaccine Protects Macaques Against SIV (March 19, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
First AIDS Vaccine Tested Did Not Protect, But Gives Scientific Leads (March 14, 2003)
In AIDS Treatment News, from AIDS Treatment News
Stirring Up Racial Concerns (March 3, 2003)
The media comes under fire for overplaying AIDSVAX's poor study results, and underplaying its possible effectiveness in some minorities.
In San Francisco Chronicle
AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close (March 2003)
In TAGline, from Treatment Action Group
The VaxGen Study (Spring 2003)
In STEP Perspective, from Seattle Treatment Education Project
Effectiveness of AIDS Vaccine May Be Overstated, Expert Says; Statistics Problem May Account for AIDSVAX Discrepancy (February 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Controversial HIV Vaccine Trial Results Disappointing (February 25, 2003)
From Canadian AIDS Treatment Information Exchange
Official Hopes to Explain AIDS Vaccine Disparities (February 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
First AIDS Vaccine in Large Test Found to Be Mostly Ineffective (February 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
NPR Reports on AIDSVAX Trial Results (RealAudio) (February 24, 2003)
From National Public Radio
Experiment Shows AIDS Vaccine Unlikely to Give Total Protection From Disease (February 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Experimental AIDS Vaccine Being Tested on Humans (January 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The HIV/AIDS Vaccine Research Effort: An Update (January 2003)
Despite many challenges, a good amount of progress has been made.
In Hopkins HIV Report
Willingness to Participate and Enroll in a Phase 3 Preventive HIV-1 Vaccine Trial (December 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
VaxGen's AIDS Vaccine to Be Reviewed by FDA (December 17, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV Trick Helps Explain Failed Vaccine Attempts (December 13, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Research From the 42nd ICAAC: Alpha-Defensins, Non-Progressors and Vaccines (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
HIV's Success Might Lie in Its Mutations (November 6, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
St. Louisan with HIV Is Fighting Off AIDS (September 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Researchers Document Rare Case of Second HIV Infection With Different Strain (September 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Expert Opinion From Barcelona: Vaccines (September/October 2002)
In Positively Aware, from Test Positive Aware Network
HIV-Specific CD8 T-Cell Activity in Uninfected Injection Drug Users Is Associated With Maintenance of Seronegativity (August 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV-1 Superinfection: AE Subtype Supplanted by B Subtype (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO
Hope for AIDS Vaccine Fades; News of Superinfection Case (July 11, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Harnessing the Immune System to Fight HIV (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO
Immune Responses in Long-Term Non-Progressors -- Lessons for Immune Reconstitution (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO
Sign of HIV Immunity Reported; Protective Responses Suspected in Two Studies (July 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV Selectively Suppresses Anti-HIV Defense Cells (May 1, 2002)
From U.S. National Institute of Allergy and Infectious Diseases
Chimp Adenovirus as New Vaccine Vector (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
Franchini's DNA Prime and NYVAC Boost Vaccine (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
Not to Be Sneezed At: Merck's HIV Vaccine Program (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
AIDS Vaccine Moves Ahead in Trials (April 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Impact of Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model (March 7, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Promise of New Vaccine Vectors, the Perils of Partial Protection (March 1, 2002)
Two new HIV vaccine studies published in the journal Nature.
In TAGline, from Treatment Action Group
Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV (November 2001)
In TAGline, from Treatment Action Group
Vaccine Stops Vaginal Transmission of HIV-Like Virus (July 23, 2001)
From Reuters Health
Simian Success (January 2001)
Vaccine study seen as significant advance, but questions remain about human applicability.
In TAGline, from Treatment Action Group
Status Report on HIV Vaccine Development (Winter 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Vaccine Advance: Monkeys Still Infected, but Protected from Illness (October 20, 2000)
In AIDS Treatment News, from AIDS Treatment News
New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment (September 22, 2000)
A study in monkeys has provided important information on how the immune response to HIV develops, why it is usually not sufficient, and how vaccine approaches might be tested more effectively in the future.
In AIDS Treatment News, from AIDS Treatment News
Promising HIV Vaccine Strategy Identified in Monkey Studies (September 20, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
Vaccine Notes from the Cent Gardes (January 2000)
In TAGline, from Treatment Action Group

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.